Cohen & Steers (CNS)
(Delayed Data from NYSE)
$81.84 USD
-0.22 (-0.27%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $81.84 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CNS 81.84 -0.22(-0.27%)
Will CNS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNS
Invesco's (IVZ) June AUM Up 1.7% on Favorable Markets, Inflows
WisdomTree (WT) May AUM Rises 3.1% on Solid Net Inflows
CNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Virtus Investment's (VRTS) May AUM Rises 1.9% Sequentially
Franklin's (BEN) May AUM Benefits From Positive Markets
Victory Capital (VCTR) Sees 2.9% Sequential Rise in May AUM
Other News for CNS
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Cohen & Steers, Inc. (CNS) Q2 2024 Earnings Call Transcript
Cohen & Steers: Still Bullish After Assessing Q2 Results And AUM Figures
COHEN & STEERS REPORTS RESULTS FOR SECOND QUARTER 2024
CNS Stock Earnings: Cohen & Steers Beats EPS, Beats Revenue for Q2 2024